+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bioinformatics Market - Global Forecast 2026-2032- Product Image
Bioinformatics Market - Global Forecast 2026-2032- Product Image
Sale

Bioinformatics Market - Global Forecast 2026-2032

  • Report

  • 189 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 6083774
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Bioinformatics Market is projected to reach USD 20.69 Billion in 2026. It is expected to continue growing at a CAGR of 13.66%, reaching USD 44.73 Billion by 2032.

Bioinformatics is now a core operating layer for modern life sciences, connecting next-generation sequencing, multi-omics, clinical informatics, population genetics, and drug discovery into a single data-driven ecosystem. The field has expanded because biological data generation has outpaced traditional laboratory interpretation: the National Human Genome Research Institute has documented the steep fall in sequencing costs from the Human Genome Project era to sub-USD 1,000 human genomes, while public resources such as UK Biobank, gnomAD, the Sequence Read Archive, the European Nucleotide Archive, and the NIH All of Us Research Program demonstrate the scale of genomic data now available for research and translational medicine.

For industry leaders, the bioinformatics market is no longer defined only by sequence alignment or annotation. Competitive advantage increasingly depends on scalable cloud computing, interoperable data standards, AI-assisted interpretation, secure clinical workflows, and evidence-ready analytics that can support precision medicine, biomarker discovery, companion diagnostics, infectious disease surveillance, and regulatory-grade submissions.

Transformative Shifts in the Bioinformatics Landscape

The bioinformatics landscape is shifting from project-based analysis to continuously operating data infrastructure. Sequencing centers, hospitals, pharmaceutical companies, contract research organizations, and public health agencies are moving from isolated pipelines toward integrated platforms capable of handling genomics, transcriptomics, proteomics, metabolomics, imaging, real-world data, and electronic health records.

A second major shift is the move from research-only bioinformatics to clinically actionable bioinformatics. Cancer genomics, rare disease diagnosis, infectious disease surveillance, pharmacogenomics, and reproductive health testing all require faster variant interpretation, stronger quality controls, and transparent audit trails. At the same time, open science initiatives and population-scale cohorts are improving reference datasets, while privacy regulation, data localization rules, and data sovereignty requirements are reshaping where and how biological data can be processed.

Cumulative Impact of Artificial Intelligence in Bioinformatics

Artificial intelligence is expanding the speed, scale, and predictive power of bioinformatics. Deep learning systems have already demonstrated measurable value in protein structure prediction, variant prioritization, image-based pathology, drug-target identification, and natural language extraction from biomedical literature. AlphaFold’s public release of predicted protein structures for more than 200 million proteins through the AlphaFold Protein Structure Database marked a significant proof point for AI-enabled computational biology.

The cumulative impact of AI is strongest when models are paired with high-quality curated data, reproducible workflows, and domain validation. In genomics and multi-omics, AI can reduce manual review burden and reveal non-linear biological patterns; however, clinical deployment requires explainability, bias testing across ancestries, cybersecurity safeguards, human oversight, and compliance with regulatory expectations for software, diagnostics, and patient data protection.

Key Regional Insights Across Global Bioinformatics

North America remains a leading region for bioinformatics adoption, supported by NIH funding, major academic medical centers, large biopharma R&D budgets, mature cloud infrastructure, and population-scale programs such as All of Us. Europe is characterized by strong public genomics programs, cross-border research networks, GDPR-driven data governance, and national initiatives such as Genomics England, France Génomique, and Germany’s medical informatics investments.

Asia-Pacific is accelerating rapidly through large sequencing capacity, government-backed precision medicine programs, and expanding biotechnology hubs in China, India, Japan, South Korea, Singapore, and Australia. Latin America is building momentum through infectious disease genomics, agricultural biotechnology, and cancer research, with Brazil and Mexico playing important roles in regional capacity building. The Middle East is investing in national genome strategies and digital health modernization, particularly in Gulf countries, while Africa’s bioinformatics growth is linked to pathogen surveillance, human genetic diversity research, and capacity-building networks such as H3Africa’s legacy in genomic research infrastructure.

Key Group Insights for Bioinformatics Adoption

Within ASEAN, Singapore anchors regional bioinformatics through biomedical research, digital health infrastructure, and strong university-industry collaboration, while Thailand, Malaysia, Indonesia, Vietnam, and the Philippines are expanding genomic surveillance, clinical research, and agricultural biotechnology capacity. The GCC is using national genome projects, hospital digitization, and precision medicine strategies to strengthen local data assets and reduce reliance on imported reference populations.

The European Union benefits from coordinated research funding, data protection frameworks, and initiatives that support secure health data exchange. BRICS economies bring scale through large patient populations, cost-competitive sequencing, public health genomics, and growing AI talent, although infrastructure maturity varies. The G7 continues to lead in high-value pharmaceutical R&D, advanced diagnostics, biomedical data standards, and cloud-enabled bioinformatics platforms, while NATO members increasingly recognize bioinformatics as relevant to biosecurity, biodefense, and resilient public health surveillance.

Key Country Insights in Bioinformatics

The United States leads in commercial bioinformatics platforms, NIH-funded genomics, FDA-regulated precision diagnostics, and venture-backed computational biology. Canada combines strong academic genomics, AI research, and population health expertise, while Mexico and Brazil are expanding clinical genomics, infectious disease research, and agricultural bioinformatics. The United Kingdom remains influential through Genomics England, UK Biobank, and NHS-linked genomics integration.

Germany, France, Italy, and Spain are advancing medical informatics, oncology genomics, rare disease research, and biobank-enabled studies, while Russia maintains capabilities in computational biology and infectious disease science despite geopolitical constraints. China is a global sequencing powerhouse with large-scale genomics capacity and AI investment; India is scaling bioinformatics through genomics programs, digital public infrastructure, and a large technology workforce. Japan, South Korea, and Australia contribute advanced clinical research, cancer genomics, proteomics, population health analytics, and translational bioinformatics capabilities.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize interoperable, cloud-ready bioinformatics architectures that can support multi-omics data integration, reproducible pipelines, and secure collaboration across research and clinical teams. Investments in FAIR data principles, standardized metadata, workflow automation, and API-driven platform design can reduce analytical bottlenecks and improve downstream evidence generation.

Organizations should also establish governance for AI-enabled bioinformatics, including model validation, bias monitoring, data provenance, cybersecurity, human-in-the-loop review, and regulatory readiness. Strategic partnerships with academic centers, sequencing providers, cloud infrastructure partners, clinical laboratories, and population health programs can accelerate innovation while improving access to diverse datasets and clinically relevant expertise.

Research Methodology

This executive summary is based on triangulated secondary research from publicly available scientific, regulatory, and institutional sources, including peer-reviewed bioinformatics literature, national genomics program disclosures, public database documentation, health agency publications, regulatory guidance, and industry-relevant technology reports. Emphasis is placed on verifiable indicators such as sequencing cost declines, public cohort scale, AI model deployment milestones, regulatory developments, and documented regional genomics initiatives.

The methodology assesses market direction through qualitative synthesis rather than speculative forecasting. Insights were structured around demand drivers, technology adoption, regional infrastructure, policy environment, clinical translation, and competitive implications for organizations operating in genomics data analytics, computational biology, precision medicine, multi-omics informatics, and AI-enabled life sciences.

Conclusion

Bioinformatics has become an essential capability for organizations competing in precision medicine, drug discovery, diagnostics, public health, and biotechnology. The convergence of lower sequencing costs, cloud-scale computation, population genomics, multi-omics integration, and AI-enabled analytics is transforming biological data into a strategic asset.

The next phase of market leadership will depend on trusted data infrastructure, validated AI workflows, regulatory-grade evidence, and the ability to translate multi-omics insights into clinical and commercial decisions. Organizations that combine scientific rigor with scalable digital execution will be best positioned to capture the long-term value of bioinformatics.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.1.1. Expansion of Biological Data Generation
4.3.1.2. Translation of Genomics Into Clinical and Drug-Development Decisions
4.3.1.3. Cloud and Managed-Service Adoption
4.3.1.4. AI-Enabled Modeling and Interpretation
4.3.1.5. Population Genomics and Public-Health Programs
4.3.2. Key Restraints
4.3.2.1. Privacy, Sovereignty, and Data-Access Constraints
4.3.2.2. Interoperability and Reproducibility Gaps
4.3.2.3. Specialist Talent and Implementation Burden
4.3.2.4. Clinical Validation and Regulatory Liability
4.3.2.5. Budget Volatility and Compute Economics
4.3.3. Key Opportunities
4.3.3.1. Decision-Ready Integrated Multi-omics
4.3.3.2. Sovereign and Federated Analytics
4.3.3.3. Managed Bioinformatics for Smaller Organizations
4.3.3.4. Explainable AI-Assisted Interpretation
4.3.3.5. Regional Genomics and Capacity Expansion
4.3.4. Key Challenges
4.3.4.1. Data Quality and Semantic Consistency
4.3.4.2. Scaling Without Losing Cost Control
4.3.4.3. AI Bias, Drift, and Accountability
4.3.4.4. Laboratory, Data, and Clinical Integration
4.3.4.5. Workforce and Organizational Adoption
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Bioinformatics Market, by Offering
7.1. Introduction
7.2. Software
7.2.1. Analysis & Workflow Software
7.2.2. Data Management & Collaboration Software
7.2.3. Interpretation & Visualization Software
7.3. Data & Knowledge Products
7.4. Services
7.4.1. Custom Analysis & Consulting Services
7.4.2. Implementation & Integration Services
7.4.3. Managed Bioinformatics Services
7.4.4. Training & Technical Support Services
8. Bioinformatics Market, by Biological Domain
8.1. Introduction
8.2. Genomics & Epigenomics
8.3. Proteomics & Protein Informatics
8.4. Integrated Multi-omics & Systems Biology
8.5. Transcriptomics
8.6. Metabolomics & Small-Molecule Informatics
8.7. Bioimage & Phenotypic Informatics
9. Bioinformatics Market, by Functional Flow
9.1. Introduction
9.2. Alignment, Assembly & Feature Detection
9.3. Annotation & Biological Interpretation
9.4. Statistical & Comparative Analysis
9.5. Data Ingestion, Management & Curation
9.6. Modeling, Prediction & Simulation
9.7. Quality Control & Preprocessing
9.8. Visualization, Reporting & Collaboration
10. Bioinformatics Market, by Integration Level
10.1. Introduction
10.2. Integrated Suites
10.3. Standalone Solutions
11. Bioinformatics Market, by Technology
11.1. Introduction
11.2. Next-Generation Sequencing (NGS) Analytics
11.3. Non-AI/ML Computational Methods
11.4. Artificial Intelligence & Machine Learning
11.5. Mass Spectrometry Analytics
11.6. CRISPR & Gene Editing Analysis
12. Bioinformatics Market, by Organization Size
12.1. Introduction
12.2. Large Enterprises
12.3. Small & Mid-Sized Enterprises
13. Bioinformatics Market, by Deployment Model
13.1. Introduction
13.2. Cloud-Based
13.2.1. Public Cloud
13.2.2. Private Cloud
13.3. On-Premises
13.4. Hybrid Deployment
14. Bioinformatics Market, by End User
14.1. Introduction
14.2. Pharmaceutical & Biotechnology Companies
14.3. Academic, Government & Nonprofit Research Institutions
14.4. Contract Research & Testing Organizations
14.5. Healthcare Providers & Clinical Laboratories
14.6. Agriculture & Food Biotechnology
14.7. Public Health & Forensic Laboratories
15. Bioinformatics Market, by Region
15.1. North America
15.2. Europe
15.3. Asia-Pacific
15.4. Latin America
15.5. Middle East
15.6. Africa
16. Bioinformatics Market, by Group
16.1. NATO
16.2. G7
16.3. European Union
16.4. BRICS
16.5. ASEAN
16.6. GCC
17. Bioinformatics Market, by Country
17.1. United States
17.2. China
17.3. United Kingdom
17.4. Japan
17.5. Germany
17.6. India
17.7. Canada
17.8. France
17.9. Australia
17.10. South Korea
17.11. Italy
17.12. Brazil
17.13. Mexico
17.14. Spain
17.15. Russia
18. Competitive Landscape
18.1. Market Share Analysis, 2025
18.2. FPNV Positioning Matrix, 2025
18.3. Market Concentration Analysis, 2025
18.3.1. Concentration Ratio (CR)
18.3.2. Herfindahl Hirschman Index (HHI)
18.4. Recent Developments & Impact Analysis, 2025
18.5. Product Portfolio Analysis, 2025
18.6. Benchmarking Analysis, 2025
19. Company Profiles
19.1. Thermo Fisher Scientific Inc.
19.2. Danaher Corporation
19.3. Illumina, Inc.
19.4. Agilent Technologies, Inc.
19.5. BGI Group
19.6. QIAGEN N.V.
19.7. F. Hoffmann-La Roche Ltd.
19.8. PerkinElmer, Inc.
19.9. Labcorp Holdings Inc.
19.10. Bio-Rad Laboratories, Inc.
19.11. Eurofins Scientific SE
19.12. Novo Nordisk A/S
19.13. DNAnexus, Inc.
19.14. Amazon Web Services, Inc.
19.15. Bruker Corporation
19.16. Benchling, Inc.
19.17. LabVantage Solutions, Inc.
19.18. Velsera Inc.
19.19. Waters Corporation
19.20. Genomics Ltd.
19.21. SOPHiA GENETICS SA
19.22. 10x Genomics, Inc.
19.23. Oxford Nanopore Technologies plc
19.24. Veracyte, Inc.
19.25. DNASTAR, Inc.
19.26. Partek Incorporated
19.27. Genomenon, Inc.
19.28. BioDiscovery Group
19.29. biomodal Limited
19.30. Dassault Systèmes SE
19.31. Fabric Genomics, Inc.
19.32. Genestack Limited
19.33. Genevia Technologies Oy
19.34. HaploX Ltd.
19.35. NVIDIA Corporation
19.36. Pacific Biosciences of California, Inc.
19.37. RIKEN GENESIS CO.,LTD.
19.38. Seqera Labs, S.L.
19.39. Telesis Bio Inc.
List of Figures
FIGURE 1. GLOBAL BIOINFORMATICS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL BIOINFORMATICS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL BIOINFORMATICS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL BIOINFORMATICS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL BIOINFORMATICS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL BIOINFORMATICS MARKET SIZE, BY OFFERING, 2025 VS 2032 (%)
FIGURE 7. GLOBAL BIOINFORMATICS MARKET SIZE, BY OFFERING, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BIOINFORMATICS MARKET SIZE, BY BIOLOGICAL DOMAIN, 2025 VS 2032 (%)
FIGURE 9. GLOBAL BIOINFORMATICS MARKET SIZE, BY BIOLOGICAL DOMAIN, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BIOINFORMATICS MARKET SIZE, BY FUNCTIONAL FLOW, 2025 VS 2032 (%)
FIGURE 11. GLOBAL BIOINFORMATICS MARKET SIZE, BY FUNCTIONAL FLOW, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL BIOINFORMATICS MARKET SIZE, BY INTEGRATION LEVEL, 2025 VS 2032 (%)
FIGURE 13. GLOBAL BIOINFORMATICS MARKET SIZE, BY INTEGRATION LEVEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL BIOINFORMATICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 15. GLOBAL BIOINFORMATICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL BIOINFORMATICS MARKET SIZE, BY ORGANIZATION SIZE, 2025 VS 2032 (%)
FIGURE 17. GLOBAL BIOINFORMATICS MARKET SIZE, BY ORGANIZATION SIZE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL BIOINFORMATICS MARKET SIZE, BY DEPLOYMENT MODEL, 2025 VS 2032 (%)
FIGURE 19. GLOBAL BIOINFORMATICS MARKET SIZE, BY DEPLOYMENT MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL BIOINFORMATICS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 21. GLOBAL BIOINFORMATICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL BIOINFORMATICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 23. GLOBAL BIOINFORMATICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL BIOINFORMATICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 25. GLOBAL BIOINFORMATICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 27. GLOBAL BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. GLOBAL BIOINFORMATICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 29. GLOBAL BIOINFORMATICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL BIOINFORMATICS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL BIOINFORMATICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL BIOINFORMATICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL ANALYSIS & WORKFLOW SOFTWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL ANALYSIS & WORKFLOW SOFTWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL ANALYSIS & WORKFLOW SOFTWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL DATA MANAGEMENT & COLLABORATION SOFTWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL DATA MANAGEMENT & COLLABORATION SOFTWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL DATA MANAGEMENT & COLLABORATION SOFTWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL INTERPRETATION & VISUALIZATION SOFTWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL INTERPRETATION & VISUALIZATION SOFTWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL INTERPRETATION & VISUALIZATION SOFTWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL DATA & KNOWLEDGE PRODUCTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL DATA & KNOWLEDGE PRODUCTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL DATA & KNOWLEDGE PRODUCTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL CUSTOM ANALYSIS & CONSULTING SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL CUSTOM ANALYSIS & CONSULTING SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL CUSTOM ANALYSIS & CONSULTING SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL IMPLEMENTATION & INTEGRATION SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL IMPLEMENTATION & INTEGRATION SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL IMPLEMENTATION & INTEGRATION SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL MANAGED BIOINFORMATICS SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL MANAGED BIOINFORMATICS SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL MANAGED BIOINFORMATICS SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL TRAINING & TECHNICAL SUPPORT SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL TRAINING & TECHNICAL SUPPORT SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL TRAINING & TECHNICAL SUPPORT SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL BIOINFORMATICS MARKET SIZE, BY BIOLOGICAL DOMAIN, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL GENOMICS & EPIGENOMICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL GENOMICS & EPIGENOMICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL GENOMICS & EPIGENOMICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL PROTEOMICS & PROTEIN INFORMATICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL PROTEOMICS & PROTEIN INFORMATICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL PROTEOMICS & PROTEIN INFORMATICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL INTEGRATED MULTI-OMICS & SYSTEMS BIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL INTEGRATED MULTI-OMICS & SYSTEMS BIOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL INTEGRATED MULTI-OMICS & SYSTEMS BIOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL TRANSCRIPTOMICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL METABOLOMICS & SMALL-MOLECULE INFORMATICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL METABOLOMICS & SMALL-MOLECULE INFORMATICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL METABOLOMICS & SMALL-MOLECULE INFORMATICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL BIOIMAGE & PHENOTYPIC INFORMATICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL BIOIMAGE & PHENOTYPIC INFORMATICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL BIOIMAGE & PHENOTYPIC INFORMATICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL BIOINFORMATICS MARKET SIZE, BY FUNCTIONAL FLOW, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL ALIGNMENT, ASSEMBLY & FEATURE DETECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL ALIGNMENT, ASSEMBLY & FEATURE DETECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL ALIGNMENT, ASSEMBLY & FEATURE DETECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL ANNOTATION & BIOLOGICAL INTERPRETATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL ANNOTATION & BIOLOGICAL INTERPRETATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL ANNOTATION & BIOLOGICAL INTERPRETATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL STATISTICAL & COMPARATIVE ANALYSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL STATISTICAL & COMPARATIVE ANALYSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL STATISTICAL & COMPARATIVE ANALYSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL DATA INGESTION, MANAGEMENT & CURATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL DATA INGESTION, MANAGEMENT & CURATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL DATA INGESTION, MANAGEMENT & CURATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL MODELING, PREDICTION & SIMULATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL MODELING, PREDICTION & SIMULATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL MODELING, PREDICTION & SIMULATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL QUALITY CONTROL & PREPROCESSING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL QUALITY CONTROL & PREPROCESSING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL QUALITY CONTROL & PREPROCESSING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL VISUALIZATION, REPORTING & COLLABORATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL VISUALIZATION, REPORTING & COLLABORATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL VISUALIZATION, REPORTING & COLLABORATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL BIOINFORMATICS MARKET SIZE, BY INTEGRATION LEVEL, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL INTEGRATED SUITES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL INTEGRATED SUITES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL INTEGRATED SUITES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL STANDALONE SOLUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL STANDALONE SOLUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL STANDALONE SOLUTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL BIOINFORMATICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL NEXT-GENERATION SEQUENCING (NGS) ANALYTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL NEXT-GENERATION SEQUENCING (NGS) ANALYTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL NEXT-GENERATION SEQUENCING (NGS) ANALYTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL NON-AI/ML COMPUTATIONAL METHODS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL NON-AI/ML COMPUTATIONAL METHODS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL NON-AI/ML COMPUTATIONAL METHODS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL ARTIFICIAL INTELLIGENCE & MACHINE LEARNING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL ARTIFICIAL INTELLIGENCE & MACHINE LEARNING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL ARTIFICIAL INTELLIGENCE & MACHINE LEARNING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL MASS SPECTROMETRY ANALYTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL MASS SPECTROMETRY ANALYTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL MASS SPECTROMETRY ANALYTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL CRISPR & GENE EDITING ANALYSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL CRISPR & GENE EDITING ANALYSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL CRISPR & GENE EDITING ANALYSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL BIOINFORMATICS MARKET SIZE, BY ORGANIZATION SIZE, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL LARGE ENTERPRISES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL LARGE ENTERPRISES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL LARGE ENTERPRISES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL SMALL & MID-SIZED ENTERPRISES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL SMALL & MID-SIZED ENTERPRISES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL SMALL & MID-SIZED ENTERPRISES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL BIOINFORMATICS MARKET SIZE, BY DEPLOYMENT MODEL, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL CLOUD-BASED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL CLOUD-BASED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL CLOUD-BASED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL PUBLIC CLOUD MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL PUBLIC CLOUD MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL PUBLIC CLOUD MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL PRIVATE CLOUD MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL PRIVATE CLOUD MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL PRIVATE CLOUD MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL ON-PREMISES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL ON-PREMISES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL ON-PREMISES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL HYBRID DEPLOYMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL HYBRID DEPLOYMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL HYBRID DEPLOYMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL BIOINFORMATICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL ACADEMIC, GOVERNMENT & NONPROFIT RESEARCH INSTITUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL ACADEMIC, GOVERNMENT & NONPROFIT RESEARCH INSTITUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL ACADEMIC, GOVERNMENT & NONPROFIT RESEARCH INSTITUTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL CONTRACT RESEARCH & TESTING ORGANIZATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL CONTRACT RESEARCH & TESTING ORGANIZATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL CONTRACT RESEARCH & TESTING ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL HEALTHCARE PROVIDERS & CLINICAL LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL HEALTHCARE PROVIDERS & CLINICAL LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL HEALTHCARE PROVIDERS & CLINICAL LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL AGRICULTURE & FOOD BIOTECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL AGRICULTURE & FOOD BIOTECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL AGRICULTURE & FOOD BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL PUBLIC HEALTH & FORENSIC LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL PUBLIC HEALTH & FORENSIC LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL PUBLIC HEALTH & FORENSIC LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL BIOINFORMATICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 141. NORTH AMERICA BIOINFORMATICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 142. NORTH AMERICA BIOINFORMATICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 143. NORTH AMERICA BIOINFORMATICS MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 144. NORTH AMERICA BIOINFORMATICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 145. NORTH AMERICA BIOINFORMATICS MARKET SIZE, BY BIOLOGICAL DOMAIN, 2017-2032 (USD MILLION)
TABLE 146. NORTH AMERICA BIOINFORMATICS MARKET SIZE, BY FUNCTIONAL FLOW, 2017-2032 (USD MILLION)
TABLE 147. NORTH AMERICA BIOINFORMATICS MARKET SIZE, BY INTEGRATION LEVEL, 2017-2032 (USD MILLION)
TABLE 148. NORTH AMERICA BIOINFORMATICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 149. NORTH AMERICA BIOINFORMATICS MARKET SIZE, BY ORGANIZATION SIZE, 2017-2032 (USD MILLION)
TABLE 150. NORTH AMERICA BIOINFORMATICS MARKET SIZE, BY DEPLOYMENT MODEL, 2017-2032 (USD MILLION)
TABLE 151. NORTH AMERICA BIOINFORMATICS MARKET SIZE, BY CLOUD-BASED, 2017-2032 (USD MILLION)
TABLE 152. NORTH AMERICA BIOINFORMATICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 153. EUROPE BIOINFORMATICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 154. EUROPE BIOINFORMATICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 155. EUROPE BIOINFORMATICS MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 156. EUROPE BIOINFORMATICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 157. EUROPE BIOINFORMATICS MARKET SIZE, BY BIOLOGICAL DOMAIN, 2017-2032 (USD MILLION)
TABLE 158. EUROPE BIOINFORMATICS MARKET SIZE, BY FUNCTIONAL FLOW, 2017-2032 (USD MILLION)
TABLE 159. EUROPE BIOINFORMATICS MARKET SIZE, BY INTEGRATION LEVEL, 2017-2032 (USD MILLION)
TABLE 160. EUROPE BIOINFORMATICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 161. EUROPE BIOINFORMATICS MARKET SIZE, BY ORGANIZATION SIZE, 2017-2032 (USD MILLION)
TABLE 162. EUROPE BIOINFORMATICS MARKET SIZE, BY DEPLOYMENT MODEL, 2017-2032 (USD MILLION)
TABLE 163. EUROPE BIOINFORMATICS MARKET SIZE, BY CLOUD-BASED, 2017-2032 (USD MILLION)
TABLE 164. EUROPE BIOINFORMATICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 165. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 166. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 167. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 168. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 169. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY BIOLOGICAL DOMAIN, 2017-2032 (USD MILLION)
TABLE 170. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY FUNCTIONAL FLOW, 2017-2032 (USD MILLION)
TABLE 171. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY INTEGRATION LEVEL, 2017-2032 (USD MILLION)
TABLE 172. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 173. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY ORGANIZATION SIZE, 2017-2032 (USD MILLION)
TABLE 174. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY DEPLOYMENT MODEL, 2017-2032 (USD MILLION)
TABLE 175. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY CLOUD-BASED, 2017-2032 (USD MILLION)
TABLE 176. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 177. LATIN AMERICA BIOINFORMATICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 178. LATIN AMERICA BIOINFORMATICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 179. LATIN AMERICA BIOINFORMATICS MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 180. LATIN AMERICA BIOINFORMATICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 181. LATIN AMERICA BIOINFORMATICS MARKET SIZE, BY BIOLOGICAL DOMAIN, 2017-2032 (USD MILLION)
TABLE 182. LATIN AMERICA BIOINFORMATICS MARKET SIZE, BY FUNCTIONAL FLOW, 2017-2032 (USD MILLION)
TABLE 183. LATIN AMERICA BIOINFORMATICS MARKET SIZE, BY INTEGRATION LEVEL, 2017-2032 (USD MILLION)
TABLE 184. LATIN AMERICA BIOINFORMATICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 185. LATIN AMERICA BIOINFORMATICS MARKET SIZE, BY ORGANIZATION SIZE, 2017-2032 (USD MILLION)
TABLE 186. LATIN AMERICA BIOINFORMATICS MARKET SIZE, BY DEPLOYMENT MODEL, 2017-2032 (USD MILLION)
TABLE 187. LATIN AMERICA BIOINFORMATICS MARKET SIZE, BY CLOUD-BASED, 2017-2032 (USD MILLION)
TABLE 188. LATIN AMERICA BIOINFORMATICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 189. MIDDLE EAST BIOINFORMATICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 190. MIDDLE EAST BIOINFORMATICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 191. MIDDLE EAST BIOINFORMATICS MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 192. MIDDLE EAST BIOINFORMATICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 193. MIDDLE EAST BIOINFORMATICS MARKET SIZE, BY BIOLOGICAL DOMAIN, 2017-2032 (USD MILLION)
TABLE 194. MIDDLE EAST BIOINFORMATICS MARKET SIZE, BY FUNCTIONAL FLOW, 2017-2032 (USD MILLION)
TABLE 195. MIDDLE EAST BIOINFORMATICS MARKET SIZE, BY INTEGRATION LEVEL, 2017-2032 (USD MILLION)
TABLE 196. MIDDLE EAST BIOINFORMATICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 197. MIDDLE EAST BIOINFORMATICS MARKET SIZE, BY ORGANIZATION SIZE, 2017-2032 (USD MILLION)
TABLE 198. MIDDLE EAST BIOINFORMATICS MARKET SIZE, BY DEPLOYMENT MODEL, 2017-2032 (USD MILLION)
TABLE 199. MIDDLE EAST BIOINFORMATICS MARKET SIZE, BY CLOUD-BASED, 2017-2032 (USD MILLION)
TABLE 200. MIDDLE EAST BIOINFORMATICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 201. AFRICA BIOINFORMATICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 202. AFRICA BIOINFORMATICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 203. AFRICA BIOINFORMATICS MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 204. AFRICA BIOINFORMATICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 205. AFRICA BIOINFORMATICS MARKET SIZE, BY BIOLOGICAL DOMAIN, 2017-2032 (USD MILLION)
TABLE 206. AFRICA BIOINFORMATICS MARKET SIZE, BY FUNCTIONAL FLOW, 2017-2032 (USD MILLION)
TABLE 207. AFRICA BIOINFORMATICS MARKET SIZE, BY INTEGRATION LEVEL, 2017-2032 (USD MILLION)
TABLE 208. AFRICA BIOINFORMATICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 209. AFRICA BIOINFORMATICS MARKET SIZE, BY ORGANIZATION SIZE, 2017-2032 (USD MILLION)
TABLE 210. AFRICA BIOINFORMATICS MARKET SIZE, BY DEPLOYMENT MODEL, 2017-2032 (USD MILLION)
TABLE 211. AFRICA BIOINFORMATICS MARKET SIZE, BY CLOUD-BASED, 2017-2032 (USD MILLION)
TABLE 212. AFRICA BIOINFORMATICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 213. GLOBAL BIOINFORMATICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 214. NATO BIOINFORMATICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 215. NATO BIOINFORMATICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 216. NATO BIOINFORMATICS MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 217. NATO BIOINFORMATICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 218. NATO BIOINFORMATICS MARKET SIZE, BY BIOLOGICAL DOMAIN, 2017-2032 (USD MILLION)
TABLE 219. NATO BIOINFORMATICS MARKET SIZE, BY FUNCTIONAL FLOW, 2017-2032 (USD MILLION)
TABLE 220. NATO BIOINFORMATICS MARKET SIZE, BY INTEGRATION LEVEL, 2017-2032 (USD MILLION)
TABLE 221. NATO BIOINFORMATICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 222. NATO BIOINFORMATICS MARKET SIZE, BY ORGANIZATION SIZE, 2017-2032 (USD MILLION)
TABLE 223. NATO BIOINFORMATICS MARKET SIZE, BY DEPLOYMENT MODEL, 2017-2032 (USD MILLION)
TABLE 224. NATO BIOINFORMATICS MARKET SIZE, BY CLOUD-BASED, 2017-2032 (USD MILLION)
TABLE 225. NATO BIOINFORMATICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 226. G7 BIOINFORMATICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 227. G7 BIOINFORMATICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 228. G7 BIOINFORMATICS MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 229. G7 BIOINFORMATICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 230. G7 BIOINFORMATICS MARKET SIZE, BY BIOLOGICAL DOMAIN, 2017-2032 (USD MILLION)
TABLE 231. G7 BIOINFORMATICS MARKET SIZE, BY FUNCTIONAL FLOW, 2017-2032 (USD MILLION)
TABLE 232. G7 BIOINFORMATICS MARKET SIZE, BY INTEGRATION LEVEL, 2017-2032 (USD MILLION)
TABLE 233. G7 BIOINFORMATICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 234. G7 BIOINFORMATICS MARKET SIZE, BY ORGANIZATION SIZE, 2017-2032 (USD MILLION)
TABLE 235. G7 BIOINFORMATICS MARKET SIZE, BY DEPLOYMENT MODEL, 2017-2032 (USD MILLION)
TABLE 236. G7 BIOINFORMATICS MARKET SIZE, BY CLOUD-BASED, 2017-2032 (USD MILLION)
TABLE 237. G7 BIOINFORMATICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 238. EUROPEAN UNION BIOINFORMATICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 239. EUROPEAN UNION BIOINFORMATICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION BIOINFORMATICS MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 241. EUROPEAN UNION BIOINFORMATICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION BIOINFORMATICS MARKET SIZE, BY BIOLOGICAL DOMAIN, 2017-2032 (USD MILLION)
TABLE 243. EUROPEAN UNION BIOINFORMATICS MARKET SIZE, BY FUNCTIONAL FLOW, 2017-2032 (USD MILLION)
TABLE 244. EUROPEAN UNION BIOINFORMATICS MARKET SIZE, BY INTEGRATION LEVEL, 2017-2032 (USD MILLION)
TABLE 245. EUROPEAN UNION BIOINFORMATICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 246. EUROPEAN UNION BIOINFORMATICS MARKET SIZE, BY ORGANIZATION SIZE, 2017-2032 (USD MILLION)
TABLE 247. EUROPEAN UNION BIOINFORMATICS MARKET SIZE, BY DEPLOYMENT MODEL, 2017-2032 (USD MILLION)
TABLE 248. EUROPEAN UNION BIOINFORMATICS MARKET SIZE, BY CLOUD-BASED, 2017-2032 (USD MILLION)
TABLE 249. EUROPEAN UNION BIOINFORMATICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 250. BRICS BIOINFORMATICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 251. BRICS BIOINFORMATICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 252. BRICS BIOINFORMATICS MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 253. BRICS BIOINFORMATICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 254. BRICS BIOINFORMATICS MARKET SIZE, BY BIOLOGICAL DOMAIN, 2017-2032 (USD MILLION)
TABLE 255. BRICS BIOINFORMATICS MARKET SIZE, BY FUNCTIONAL FLOW, 2017-2032 (USD MILLION)
TABLE 256. BRICS BIOINFORMATICS MARKET SIZE, BY INTEGRATION LEVEL, 2017-2032 (USD MILLION)
TABLE 257. BRICS BIOINFORMATICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 258. BRICS BIOINFORMATICS MARKET SIZE, BY ORGANIZATION SIZE, 2017-2032 (USD MILLION)
TABLE 259. BRICS BIOINFORMATICS MARKET SIZE, BY DEPLOYMENT MODEL, 2017-2032 (USD MILLION)
TABLE 260. BRICS BIOINFORMATICS MARKET SIZE, BY CLOUD-BASED, 2017-2032 (USD MILLION)
TABLE 261. BRICS BIOINFORMATICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 262. ASEAN BIOINFORMATICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 263. ASEAN BIOINFORMATICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 264. ASEAN BIOINFORMATICS MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 265. ASEAN BIOINFORMATICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 266. ASEAN BIOINFORMATICS MARKET SIZE, BY BIOLOGICAL DOMAIN, 2017-2032 (USD MILLION)
TABLE 267. ASEAN BIOINFORMATICS MARKET SIZE, BY FUNCTIONAL FLOW, 2017-2032 (USD MILLION)
TABLE 268. ASEAN BIOINFORMATICS MARKET SIZE, BY INTEGRATION LEVEL, 2017-2032 (USD MILLION)
TABLE 269. ASEAN BIOINFORMATICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 270. ASEAN BIOINFORMATICS MARKET SIZE, BY ORGANIZATION SIZE, 2017-2032 (USD MILLION)
TABLE 271. ASEAN BIOINFORMATICS MARKET SIZE, BY DEPLOYMENT MODEL, 2017-2032 (USD MILLION)
TABLE 272. ASEAN BIOINFORMATICS MARKET SIZE, BY CLOUD-BASED, 2017-2032 (USD MILLION)
TABLE 273. ASEAN BIOINFORMATICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 274. GCC BIOINFORMATICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 275. GCC BIOINFORMATICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 276. GCC BIOINFORMATICS MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 277. GCC BIOINFORMATICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 278. GCC BIOINFORMATICS MARKET SIZE, BY BIOLOGICAL DOMAIN, 2017-2032 (USD MILLION)
TABLE 279. GCC BIOINFORMATICS MARKET SIZE, BY FUNCTIONAL FLOW, 2017-2032 (USD MILLION)
TABLE 280. GCC BIOINFORMATICS MARKET SIZE, BY INTEGRATION LEVEL, 2017-2032 (USD MILLION)
TABLE 281. GCC BIOINFORMATICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 282. GCC BIOINFORMATICS MARKET SIZE, BY ORGANIZATION SIZE, 2017-2032 (USD MILLION)
TABLE 283. GCC BIOINFORMATICS MARKET SIZE, BY DEPLOYMENT MODEL, 2017-2032 (USD MILLION)
TABLE 284. GCC BIOINFORMATICS MARKET SIZE, BY CLOUD-BASED, 2017-2032 (USD MILLION)
TABLE 285. GCC BIOINFORMATICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 286. GLOBAL BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 287. UNITED STATES BIOINFORMATICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 288. UNITED STATES BIOINFORMATICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 289. UNITED STATES BIOINFORMATICS MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 290. UNITED STATES BIOINFORMATICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 291. UNITED STATES BIOINFORMATICS MARKET SIZE, BY BIOLOGICAL DOMAIN, 2017-2032 (USD MILLION)
TABLE 292. UNITED STATES BIOINFORMATICS MARKET SIZE, BY FUNCTIONAL FLOW, 2017-2032 (USD MILLION)
TABLE 293. UNITED STATES BIOINFORMATICS MARKET SIZE, BY INTEGRATION LEVEL, 2017-2032 (USD MILLION)
TABLE 294. UNITED STATES BIOINFORMATICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 295. UNITED STATES BIOINFORMATICS MARKET SIZE, BY ORGANIZATION SIZE, 2017-2032 (USD MILLION)
TABLE 296. UNITED STATES BIOINFORMATICS MARKET SIZE, BY DEPLOYMENT MODEL, 2017-2032 (USD MILLION)
TABLE 297. UNITED STATES BIOINFORMATICS MARKET SIZE, BY CLOUD-BASED, 2017-2032 (USD MILLION)
TABLE 298. UNITED STATES BIOINFORMATICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 299. CHINA BIOINFORMATICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 300. CHINA BIOINFORMATICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 301. CHINA BIOINFORMATICS MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 302. CHINA BIOINFORMATICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 303. CHINA BIOINFORMATICS MARKET SIZE, BY BIOLOGICAL DOMAIN, 2017-2032 (USD MILLION)
TABLE 304. CHINA BIOINFORMATICS MARKET SIZE, BY FUNCTIONAL FLOW, 2017-2032 (USD MILLION)
TABLE 305. CHINA BIOINFORMATICS MARKET SIZE, BY INTEGRATION LEVEL, 2017-2032 (USD MILLION)
TABLE 306. CHINA BIOINFORMATICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 307. CHINA BIOINFORMATICS MARKET SIZE, BY ORGANIZATION SIZE, 2017-2032 (USD MILLION)
TABLE 308. CHINA BIOINFORMATICS MARKET SIZE, BY DEPLOYMENT MODEL, 2017-2032 (USD MILLION)
TABLE 309. CHINA BIOINFORMATICS MARKET SIZE, BY CLOUD-BASED, 2017-2032 (USD MILLION)
TABLE 310. CHINA BIOINFORMATICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 311. UNITED KINGDOM BIOINFORMATICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 312. UNITED KINGDOM BIOINFORMATICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 313. UNITED KINGDOM BIOINFORMATICS MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 314. UNITED KINGDOM BIOINFORMATICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 315. UNITED KINGDOM BIOINFORMATICS MARKET SIZE, BY BIOLOGICAL DOMAIN, 2017-2032 (USD MILLION)
TABLE 316. UNITED KINGDOM BIOINFORMATICS MARKET SIZE, BY FUNCTIONAL FLOW, 2017-2032 (USD MILLION)
TABLE 317. UNITED KINGDOM BIOINFORMATICS MARKET SIZE, BY INTEGRATION LEVEL, 2017-2032 (USD MILLION)
TABLE 318. UNITED KINGDOM BIOINFORMATICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 319. UNITED KINGDOM BIOINFORMATICS MARKET SIZE, BY ORGANIZATION SIZE, 2017-2032 (USD MILLION)
TABLE 320. UNITED KINGDOM BIOINFORMATICS MARKET SIZE, BY DEPLOYMENT MODEL, 2017-2032 (USD MILLION)
TABLE 321. UNITED KINGDOM BIOINFORMATICS MARKET SIZE, BY CLOUD-BASED, 2017-2032 (USD MILLION)
TABLE 322. UNITED KINGDOM BIOINFORMATICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 323. JAPAN BIOINFORMATICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 324. JAPAN BIOINFORMATICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 325. JAPAN BIOINFORMATICS MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 326. JAPAN BIOINFORMATICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 327. JAPAN BIOINFORMATICS MARKET SIZE, BY BIOLOGICAL DOMAIN, 2017-2032 (USD MILLION)
TABLE 328. JAPAN BIOINFORMATICS MARKET SIZE, BY FUNCTIONAL FLOW, 2017-2032 (USD MILLION)
TABLE 329. JAPAN BIOINFORMATICS MARKET SIZE, BY INTEGRATION LEVEL, 2017-2032 (USD MILLION)
TABLE 330. JAPAN BIOINFORMATICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 331. JAPAN BIOINFORMATICS MARKET SIZE, BY ORGANIZATION SIZE, 2017-2032 (USD MILLION)
TABLE 332. JAPAN BIOINFORMATICS MARKET SIZE, BY DEPLOYMENT MODEL, 2017-2032 (USD MILLION)
TABLE 333. JAPAN BIOINFORMATICS MARKET SIZE, BY CLOUD-BASED, 2017-2032 (USD MILLION)
TABLE 334. JAPAN BIOINFORMATICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 335. GERMANY BIOINFORMATICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 336. GERMANY BIOINFORMATICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 337. GERMANY BIOINFORMATICS MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 338. GERMANY BIOINFORMATICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 339. GERMANY BIOINFORMATICS MARKET SIZE, BY BIOLOGICAL DOMAIN, 2017-2032 (USD MILLION)
TABLE 340. GERMANY BIOINFORMATICS MARKET SIZE, BY FUNCTIONAL FLOW, 2017-2032 (USD MILLION)
TABLE 341. GERMANY BIOINFORMATICS MARKET SIZE, BY INTEGRATION LEVEL, 2017-2032 (USD MILLION)
TABLE 342. GERMANY BIOINFORMATICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 343. GERMANY BIOINFORMATICS MARKET SIZE, BY ORGANIZATION SIZE, 2017-2032 (USD MILLION)
TABLE 344. GERMANY BIOINFORMATICS MARKET SIZE, BY DEPLOYMENT MODEL, 2017-2032 (USD MILLION)
TABLE 345. GERMANY BIOINFORMATICS MARKET SIZE, BY CLOUD-BASED, 2017-2032 (USD MILLION)
TABLE 346. GERMANY BIOINFORMATICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 347. INDIA BIOINFORMATICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 348. INDIA BIOINFORMATICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 349. INDIA BIOINFORMATICS MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 350. INDIA BIOINFORMATICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 351. INDIA BIOINFORMATICS MARKET SIZE, BY BIOLOGICAL DOMAIN, 2017-2032 (USD MILLION)
TABLE 352. INDIA BIOINFORMATICS MARKET SIZE, BY FUNCTIONAL FLOW, 2017-2032 (USD MILLION)
TABLE 353. INDIA BIOINFORMATICS MARKET SIZE, BY INTEGRATION LEVEL, 2017-2032 (USD MILLION)
TABLE 354. INDIA BIOINFORMATICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 355. INDIA BIOINFORMATICS MARKET SIZE, BY ORGANIZATION SIZE, 2017-2032 (USD MILLION)
TABLE 356. INDIA BIOINFORMATICS MARKET SIZE, BY DEPLOYMENT MODEL, 2017-2032 (USD MILLION)
TABLE 357. INDIA BIOINFORMATICS MARKET SIZE, BY CLOUD-BASED, 2017-2032 (USD MILLION)
TABLE 358. INDIA BIOINFORMATICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 359. CANADA BIOINFORMATICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 360. CANADA BIOINFORMATICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 361. CANADA BIOINFORMATI

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • BGI Group
  • QIAGEN N.V.
  • F. Hoffmann-La Roche Ltd.
  • PerkinElmer, Inc.
  • Labcorp Holdings Inc.
  • Bio-Rad Laboratories, Inc.
  • Eurofins Scientific SE
  • Novo Nordisk A/S
  • DNAnexus, Inc.
  • Amazon Web Services, Inc.
  • Bruker Corporation
  • Benchling, Inc.
  • LabVantage Solutions, Inc.
  • Velsera Inc.
  • Waters Corporation
  • Genomics Ltd.
  • SOPHiA GENETICS SA
  • 10x Genomics, Inc.
  • Oxford Nanopore Technologies plc
  • Veracyte, Inc.
  • DNASTAR, Inc.
  • Partek Incorporated
  • Genomenon, Inc.
  • BioDiscovery Group
  • biomodal Limited
  • Dassault Systèmes SE
  • Fabric Genomics, Inc.
  • Genestack Limited
  • Genevia Technologies Oy
  • HaploX Ltd.
  • NVIDIA Corporation
  • Pacific Biosciences of California, Inc.
  • RIKEN GENESIS CO.,LTD.
  • Seqera Labs, S.L.
  • Telesis Bio Inc.

Table Information

Report AttributeDetails
No. of Pages189
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 20.69 Billion
Forecasted Market Value ( USD ) by 2032 $ 44.73 Billion
Compound Annual Growth Rate13.6%
Regions CoveredGlobal
No. of Companies Mentioned39

Related Topics

Related Reports

2024 Latin America Bioinformatics Market Forecast (2025-2030 Outlook) - Market Opportunities Report - Product Image

2024 Latin America Bioinformatics Market Forecast (2025-2030 Outlook) - Market Opportunities Report

  • Report
  • 70 Pages
  • Latin America
From
Bioinformatics Services Market - Global Forecast 2026-2032 - Product Image

Bioinformatics Services Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Single Cell Bioinformatics Software & Services Market - Global Forecast 2026-2032 - Product Image

Single Cell Bioinformatics Software & Services Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Bioinformatics - Global Strategic Business Report - Product Image

Bioinformatics - Global Strategic Business Report

  • Report
  • 438 Pages
  • Global
From
Bioinformatics Services Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Bioinformatics Services Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 216 Pages
  • Global
From

About the Bioinformatics Market

Bioinformatics is the application of computer science and information technology to the field of biology and medicine. It involves the development of software tools and databases to analyze and interpret biological data. Bioinformatics is used to study genes and proteins, to understand the structure and function of biological systems, and to develop new drugs and treatments. Bioinformatics is a rapidly growing field, with many companies offering products and services to support research and development. Companies such as Illumina, Thermo Fisher Scientific, and Qiagen provide sequencing and analysis tools, while companies such as Bio-Rad and Agilent Technologies offer instrumentation and reagents. Other companies, such as IBM and Microsoft, provide cloud-based solutions for data storage and analysis. Additionally, there are many software companies that specialize in bioinformatics, such as CLC Bio, Partek, and GeneGo. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.